Michael J. Walsh

Mr. Michael J.
Walsh is a President, Secretary, Director and CFO at Evida Biosciences, Inc. He is on the Board of Directors at Kanisa Pharmaceuticals, Inc. and Evida Biosciences, Inc. Mr. Walsh was previously employed as a Chief Commercial Officer & EVP by Cypress Bioscience, Inc., a Chairman & Chief Executive Officer by Proprius Pharmaceuticals, Inc., an Executive Chairman by Prometheus Laboratories, Inc., a Manager-Therapeutic Operations by La Jolla Pharmaceutical Co., a Chairman by Oculir, Inc., a Director-Worldwide Marketing & European Operations by Quidel Corp., and a Partner by Windamere Venture Partners LLC.
He also served on the board at Exagen, Inc. He received his undergraduate degree from the University of Notre Dame and an MBA from Pepperdine University.